400 00145050en Voralux HF 4001 Polyol
400 00145050en Voralux HF 4001 Polyol
400 00145050en Voralux HF 4001 Polyol
VORALUX™ HF 4001
Polyol
Description VORALUXTM HF 4001 Polyol is a high performance polyether polyol especially designed for the production of High
Resilience (HR) and Combustion Modified High Resilience (CMHR) flexible slabstock foams.
Benefits VORALUXTM HF 4001 Polyol may be used to produce very high resilience foam with outstanding feel and properties.
Best in class processing performance can be obtained covering a broad density and hardness range when used in
combination with VORALUXTM WH 4043 Polyol.
Notes
These are typical properties only and are not to be construed as specifications. Users should confirm results by their own tests.
For other physical properties including, but not limited to: Boiling and Melting point, Vapor Pressure, Flash Point and Thermal
Expansion, please see section 9 of the Material Safety Data Sheet (MSDS). For Storage / shelf life information see section 7 of the
MSDS and for CAS numbers see section 3.
Safety Precautions
Most Dow Polyols generally present no significant hazard during use when simple precautions are followed. However, some polyols
may present certain hazards.
All persons who work with these materials must know and follow proper safe handling procedures.
Handling
Avoid contact with eyes, skin, or clothing. Workers should wear appropriate eye protection. Safety glasses are considered a minimum
requirement. If there is the possibility of exposure to the eyes, chemical workers’ goggles must be worn.
When working with Dow polyols, avoid contact of polyol with eyes or skin. Safety glasses are suggested for use with most polyols.
However, some Dow polyols require that chemical workers’ goggles be worn.
Please review the SDS for the specific product and your country for this information.
Toxicity
Most Dow polyols generally present no significant hazard during use when simple precautions are followed. However, some polyols
may present certain hazards. See SDS for specific information.
Eye contact
Flush eyes with water for at least 15 minutes. Obtain prompt medical attention.
Skin contact
Skin contaminated with polyols should be washed with soap and plenty of water. If irritation occurs from contact with polyols, get prompt
medical attention.
Ingestion
If a polyol is swallowed, give large amounts of water to dilute, but never give fluids or induce vomiting if patient is unconscious or is
having convulsions. Obtain medical attention.
Customer Dow strongly encourages its customers to review both their manufacturing processes and their
applications of Dow products from the standpoint of human health and environmental quality to ensure
Notice that Dow products are not used in ways for which they are not intended or tested. Dow personnel are
available to answer your questions and to provide reasonable technical support. Dow product literature,
including safety data sheets, should be consulted prior to use of Dow products. Current safety data sheets
are available from Dow.
Medical NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS: Dow will not knowingly sell or sample
any product or service (“Product”) into any commercial or developmental application that is intended for:
Applications Policy a. long-term or permanent contact with internal bodily fluids or tissues. “Long-term” is contact which
exceeds 72 continuous hours;
b. use in cardiac prosthetic devices regardless of the length of time involved (“cardiac prosthetic devices”
include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic
balloons and control systems, and ventricular bypass-assisted devices);
c. use as a critical component in medical devices that support or sustain human life; or
d. use specifically by pregnant women or in applications designed specifically to promote or interfere with
human reproduction.
Dow requests that customers considering use of Dow products in medical applications notify Dow so that
appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for
specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer
to determine that the Dow product is safe, lawful, and technically suitable for the intended use. DOW
MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW
PRODUCT FOR USE IN MEDICAL APPLICATIONS.
Disclaimer NOTICE: No freedom from infringement of any patent owned by Dow or others is to be inferred. Because
use conditions and applicable laws may differ from one location to another and may change with time, the
Customer is responsible for determining whether products and the information in this document are
appropriate for the Customer’s use and for ensuring that the Customer’s workplace and disposal practices
are in compliance with applicable laws and other governmental enactments. Dow assumes no obligation
or liability for the information in this document. NO WARRANTIES ARE GIVEN; ALL IMPLIED
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE ARE
EXPRESSLY EXCLUDED.
NOTICE: If products are described as “experimental” or “developmental”: (1) product specifications may not be fully determined;
(2) analysis of hazards and caution in handling and use are required; (3) there is greater potential for Dow to change specifications
and/or discontinue production; and (4) although Dow may from time to time provide samples of such products, Dow is not obligated
to supply or otherwise commercialize such products for any use or application whatsoever.
NOTICE: This data is based on information Dow believes to be reliable, as demonstrated in controlled
laboratory testing. They are offered in good faith, but without guarantee, as conditions and method of use
of Dow products are beyond Dow’s control. Dow recommends that the prospective user determine the
suitability of these materials and suggestions before adopting them on a commercial scale.
To the best of our knowledge, the information contained herein is accurate and reliable as of the date of
publication, however we do not assume any liability for the accuracy and completeness of such
information.
Published: